Phase I trial to evaluate safety, pharmacokinetics, and efficacy of sorafenib combined with docetaxel in patients with advanced, refractory solid tumors

被引：0
|
作者：
Awada, A.
Hendlisz, A.
Whenham, N.
Gil, T.
Christensen, O.
Lathia, C.
Bartholomeus, S.
Delabaye, I.
De Valeriola, D.
Brendel, E.
Delaunoit, T.
Piccart, M.
机构：
[1] Jules Bordet Inst, Brussels, Belgium
[2] Bayer Pharmaceut Corp, West Haven, CT USA
[3] Bayer HealthCare, Wuppertal, Germany
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours
    Awada, Ahmad
    Hendlisz, Alain
    Christensen, Olaf
    Lathia, Chetan D.
    Bartholomeus, Sylvie
    Lebrun, Fabienne
    de Valeriola, Dominique
    Brendel, Erich
    Radtke, Martin
    Delaunoit, Thierry
    Piccart-Gebhart, Martine
    Gil, Thierry
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) : 465 - 474
  • [2] Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial
    Awada, Ahmad
    Gil, Thierry
    Whenham, Nicolas
    Van Hamme, Julie
    Besse-Hammer, Tatiana
    Brendel, Erich
    Delesen, Heinz
    Joosten, Miranda C.
    Lathia, Chetan D.
    Loembe, Bienvenu A.
    Piccart-Ghebart, Martine
    Hendlisz, Alain
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (12): : 1674 - 1684
  • [3] Phase I dose-escalation trial evaluating the safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors
    Awada, A.
    Gil, T.
    Whenham, N.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Loembe, B.
    Piccart, M.
    Hendlisz, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 39 - 39
  • [4] A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors
    Puglisi, Martina
    Molife, L. Rhoda
    de Jonge, Maja J. A.
    Khan, Khurum H.
    Doorn, Leni van
    Forster, Martin D.
    Blanco, Montserrat
    Gutierrez, Martin
    Franklin, Catherine
    Busman, Todd
    Yang, Jianning
    Eskens, Ferry A. L. M.
    FUTURE ONCOLOGY, 2021, 17 (21) : 2747 - 2758
  • [5] Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical Trial
    Cheng, Ke
    Li, Xiao-Yu
    Zhou, Yu-Wen
    Liao, Zheng-Yin
    Qiu, Meng
    Bi, Feng
    Zheng, Li
    ONCOLOGIST, 2021, 26 (08): : 649 - +
  • [6] Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: A review of four phase I trials in patients with advanced refractory solid tumors
    Strumberg, Dirk
    Clark, Jeffrey W.
    Awada, Ahmad
    Moore, Malcolm J.
    Richly, Heike
    Hendlisz, Alain
    Hirte, Hal W.
    Eder, Joseph P.
    Lenz, Heinz-Josef
    Schwartz, Brian
    ONCOLOGIST, 2007, 12 (04): : 426 - 437
  • [7] A phase I trial of bexarotene and docetaxel in patients with advanced solid tumors
    Malik, S. M.
    Marshall, J. L.
    Ramzi, P.
    Deeken, J. F.
    Pishvaian, M. J.
    Hwang, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A phase I/II study to evaluate the safety, pharmacokinetics, and efficacy of PRJ1-3024 in patients with advanced solid tumors
    Zhang, Panpan
    Qin, Yanru
    Gong, Jifang
    Wang, Yongsheng
    Yang, Kunyu
    Li, Yongsheng
    Dai, Guanghai
    Zhu, Ji
    Sha, Sha
    Tong, Ming
    Liao, Xuebin
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors
    Kao, Chien-Chang
    Ho, Ching-Liang
    Yang, Ming-Hsin
    Tsai, Yi-Ta
    Liu, Shu-Yu
    Chang, Ping-Ying
    Wu, Yi-Ying
    Chen, Jia-Hong
    Yehn, Ren-Hua
    Dai, Ming-Shen
    Chen, Yeu-Chin
    Sun, Guang-Huan
    Cha, Tai-Lung
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [10] A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
    Syma Iqbal
    Heinz-Josef Lenz
    David R. Gandara
    Stephen I. Shibata
    Susan Groshen
    Timothy W. Synold
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 85 - 91
12345